Literature DB >> 19576172

Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.

Toshinori Ozaki1, Rintaro Okoshi, Sayaka Ono, Natsumi Kubo, Akira Nakagawara.   

Abstract

The expression of tumor suppressor p73 is regulated at mRNA and protein levels. It has been shown that E2F1 acts as a transcriptional activator for p73. In this study, we have found that deregulated expression of E2F1 increases the mRNA level of p73, however, E2F1 promotes the degradation of p73. Immunoprecipitation experiments demonstrated that E2F1 forms a complex with p73 and inhibits the transcriptional activity of p73. Enforced expression of E2F1 induces degradation of p73 in a proteasome-independent manner. Additionally, the deletion analysis showed that E2F1(1-117) has an undetectable effect on p73, whereas E2F1(1-285) and E2F1(1-414) have an ability to promote degradation of p73 and inhibition of p73 transcriptional activity, suggesting that the region of E2F1 between amino acid residues 118 and 285 has a critical role in the regulation of p73. Taken together, our present study indicates that E2F1 has a dual role in the regulation of p73.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576172     DOI: 10.1016/j.bbrc.2009.06.141

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα.

Authors:  Lei Zhang; Qian Zhou; Ning Zhang; Weixu Li; Meidan Ying; Wanjing Ding; Bo Yang; Qiaojun He
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

Review 2.  p53 Family and Cellular Stress Responses in Cancer.

Authors:  Johanna Pflaum; Sophie Schlosser; Martina Müller
Journal:  Front Oncol       Date:  2014-10-21       Impact factor: 6.244

3.  Mechanisms of Survival of Cytomegalovirus-Infected Tumor Cells.

Authors:  G R Vinogradskaya; A V Ivanov; A A Kushch
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.